IRD · Opus Genetics, Inc. · Documents

May 1

Proxy statement DEF 14A Meeting Jun 6, 2023

Proxy statement

May 1

Annual report to holders ARS

Annual report to holders

Apr 21

Current report 8-K Events of Apr 19

Director or officer change, or executive pay, Regulation FD disclosure

Mar 30

Current report 8-K

Financial results

Mar 30

Annual report 10-K FY2022, ended Dec 31

Annual report for FY2022

Revenue $39.85M ▲ 6665.7% Net income $17.89M Diluted EPS $0.87

Jan 25

Current report 8-K

Regulation FD disclosure, Other events

Dec 6

Current report 8-K

Other events

Nov 7

Current report 8-K Events of Nov 6

Entered into a material agreement

Nov 4

Current report 8-K

Financial results

Nov 4

Quarterly report 10-Q FY2022 Q3, ended Sep 30

Quarterly report for FY2022 Q3

Revenue $0 Net loss $4.53M Diluted EPS -$0.22

Oct 14

Current report 8-K

Regulation FD disclosure

Aug 12

Current report 8-K

Financial results, Regulation FD disclosure

Aug 12

Quarterly report 10-Q FY2022 Q2, ended Jun 30

Quarterly report for FY2022 Q2

Revenue $0 Net loss $4.93M Diluted EPS -$0.25

Jun 17

Current report 8-K Events of Jun 13

Charter or bylaw amendment, or fiscal year change, Shareholder vote results

Jun 10

Current report 8-K

Charter or bylaw amendment, or fiscal year change

Jun 10

Proxy statement DEFA14A

Proxy statement

Jun 2

Proxy statement DEFA14A

Proxy statement

May 19

Current report 8-K

Regulation FD disclosure, Other events

May 13

Current report 8-K

Financial results

May 13

Quarterly report 10-Q FY2022 Q1, ended Mar 31

Quarterly report for FY2022 Q1

Net loss $6.6M Diluted EPS -$0.35

Apr 28

Current report 8-K

Other events

Apr 27

Proxy statement DEF 14A Meeting Jun 13, 2022

Proxy statement

Apr 27

Proxy statement DEFA14A

Proxy statement

Mar 29

Current report 8-K

Regulation FD disclosure, Other events

Mar 24

Current report 8-K

Financial results

Mar 24

Annual report 10-K FY2021, ended Dec 31

Annual report for FY2021

Revenue $589K Net loss $56.69M Diluted EPS -$3.82

Jan 31

Current report 8-K

Other events

Jan 31

Current report 8-K

Regulation FD disclosure

Jan 5

Current report 8-K

Regulation FD disclosure

Nov 15

Current report 8-K Events of Nov 12

Financial results, Regulation FD disclosure

Nov 12

Quarterly report 10-Q FY2021 Q3, ended Sep 30

Quarterly report for FY2021 Q3

Revenue $489K Net loss $4.23M Diluted EPS -$0.25

Aug 12

Current report 8-K

Financial results, Regulation FD disclosure

Aug 12

Quarterly report 10-Q FY2021 Q2, ended Jun 30

Quarterly report for FY2021 Q2

Revenue $100K Net loss $7.14M Diluted EPS -$0.52

Jun 30

Current report 8-K

Regulation FD disclosure, Other events

Jun 23

Current report 8-K Events of Jun 16

Entered into a material agreement

Jun 8

Current report 8-K Events of Jun 7

Shareholder vote results, Other events

Jun 7

Current report 8-K/A Events of Jun 4

Entered into a material agreement, Other events

Jun 4

Current report 8-K

Entered into a material agreement, Other events

May 7

Current report 8-K

Financial results

May 7

Quarterly report 10-Q FY2021 Q1, ended Mar 31

Quarterly report for FY2021 Q1

Net loss $39.01M Diluted EPS -$3.57

Apr 26

Proxy statement DEF 14A Meeting Jun 7, 2021

Proxy statement

Apr 26

Proxy statement DEFA14A

Proxy statement

Apr 12

Current report 8-K Events of Apr 9

Other events

Mar 15

Current report 8-K

Regulation FD disclosure, Other events

Mar 11

Current report 8-K

Entered into a material agreement

Mar 11

Current report 8-K Events of Mar 10

Financial results

Mar 11

Annual report 10-K FY2020, ended Dec 31

Annual report for FY2020

Net loss $24.62M

Feb 11

Registration statement S-3/A

Registration statement

Feb 4

Current report 8-K Events of Feb 3

Entered into a material agreement

Feb 4

Registration statement S-3

Registration statement